City

Overall Status

Withdrawn (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Vanderbilt-Ingram Cancer Center (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

capecitabine (1)

laboratory biomarker analysis (1)

pharmacological study (1)

temozolomide (1)

veliparib (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (1)

Study Type

Interventional (1)

malignant somatostatinoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Functional Pancreatic Neuroendocrine Tumor, Malignant Somatostatinoma, Merkel Cell Carcinoma Trial (Capecitabine, Temozolomide,

Withdrawn

Functional Pancreatic Neuroendocrine Tumor
+28 more

Capecitabine
+4 more

(no location specified)

Sep 26, 2017